Analysis | Metabolite Name | Measured Value | Units | Cell Type | Stimulation |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 13529 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | 16089 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | BS4 | IFN-G | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | BS4 | Untreated | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | HAHA | IFN-G | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | HAHA | IL-17A | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | HAHA | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | HAHA | Untreated | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | PAK | IFN-G | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | PAK | IL-17A | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | PAK | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | D-ORNITHINE (CAS# 348-66-3); (M-H)- | Peak area | PAK | Untreated | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 13529 | Peak area | BS4 | IL-17A |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | 16089 | Peak area | BS4 | TNF-alpha |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | BS4 | IFN-G | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | BS4 | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | BS4 | Untreated | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | HAHA | IFN-G | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | HAHA | IL-17A | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | HAHA | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | HAHA | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | HAHA | Untreated | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | PAK | IFN-G | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | PAK | IL-17A | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | PAK | TNF-alpha | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | PAK | TNF-alpha+IL-17A | |
Reversed phase NEGATIVE ION MODE | L-ORNITHINE (CAS# 70-26-8); (M-H)- | Peak area | PAK | Untreated |